OncoSil Medical (ASX: OSL) has appointed Lawrence Gozlan as an independent non-executive director and Peter Casey as the joint company secretary with effect from today.
Gozlan is an experienced and successful biotechnology industry professional, with particular expertise in investment management and corporate advice in the life science sector.
He is the founder and chief investment officer of specialised global life sciences investment fund, Scientia Capital.
Prior to establishing Scientia Capital, Gozlan managed Australia's largest biotechnology investment portfolio, as the institutional biotechnology analyst at Queensland Investment Corporation (QIC), which has more than $60 billion under management.
Casey is a senior finance executive with extensive company secretarial knowledge.
He has worked for a private investment group as a senior finance executive with a wide range of duties, for more than 20 years.
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX "Small and Mid-cap" stocks with distribution in Australia, UK, North America and Hong Kong / China.